文献速递眼底病与葡萄膜炎

糖尿病视网膜病变的三维脉络膜血管评估

Three-Dimensional Choroidal Vessels Assessment in Diabetic Retinopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

本研究采用新型三维算法评估糖尿病视网膜病变(DR)患眼的脉络膜血管。回顾性横断面研究纳入73只DR眼和27只年龄匹配对照眼,DR眼平均脉络膜血管直径(MChVD)和脉络膜血管指数(CVI)降低,糖尿病黄斑水肿(DME)眼CVI显著降低。

要点

  • DR眼平均MChVD较健康对照降低(200.472±28.246 µm vs 240.264±22.350 µm,P<0.001)。
  • DR眼整体CVI降低,尤其颞侧和中央区域(P<0.05)。
  • DME眼平均CVI显著低于非DME眼(0.365±0.032 vs 0.389±0.040,P=0.008)。

核心结论

  • DR和DME眼显示MChVD和CVI降低,可能由微血管改变导致缺血所致,这些发现强调需要新的脉络膜生物标志物以更好理解DR的致病机制。

研究设计与样本

  • 回顾性横断面研究,纳入45例DR患者的73只眼(36只增殖性DR vs 37只非增殖性DR,42只伴DME vs 31只不伴DME)和21例年龄匹配对照的27只眼,使用扫频源光学相干断层扫描(PlexElite-9000)检查,脉络膜层用ResUNet模型分割,Phansalkar阈值法二值化脉络膜血管,黄斑区分为5个扇区并测量每个扇区15条最大血管的平均脉络膜血管直径(MChVD),计算脉络膜厚度(ChT)和脉络膜血管指数(CVI),采用线性混合模型分析。

主要发现

  • DR眼平均MChVD较健康对照降低(200.472±28.246 µm vs 240.264±22.350 µm,P<0.001),各扇区MChVD亦降低(P<0.001),但两组平均ChT无差异(P>0.05)。
  • DR眼整体CVI降低,尤其颞侧和中央扇区(P<0.05)。
  • 增殖性DR较非增殖性DR显示ChT降低(颞侧P<0.05;其他扇区P>0.05)、CVI降低(P>0.05)和MChVD降低(P>0.05)。
  • DME眼较非DME眼MChVD降低但未达统计学显著(196.449±27.221 µm vs 205.922±29.134 µm,P>0.05),平均CVI显著降低(0.365±0.032 vs 0.389±0.040,P=0.008)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate choroidal vasculature in eyes with diabetic retinopathy (DR) using a novel three-dimensional algorithm. METHODS: Patients with DR and healthy controls underwent clinical examinations and swept-source optical coherence tomography (PlexElite-9000). The choroidal layer was segmented using the ResUNet model. Phansalkar thresholding was used to binarize the choroidal vasculature. The macular area was divided into 5 sectors by a custom grid, and the 15 largest vessels in each sector were measured for mean choroidal vessel diameter (MChVD). Volumetric choroidal thickness (ChT) and the choroidal vascularity index (CVI) were calculated. A linear mixed model was used for analysis. RESULTS: This retrospective cross-sectional study analyzed 73 eyes of 45 patients with DR (36 proliferative vs. 37 nonproliferative DR, and 42 with diabetic macular edema [DME] vs. 31 without DME), and 27 eyes of 21 age-match controls. The average MChVD was decreased in DR compared with healthy (200.472 ± 28.246 µm vs. 240.264 ± 22.350 µm; P < 0.001), as well as lower sectoral MChVD (P < 0.001); however, there was no difference in average ChT between the groups (P > 0.05). The global CVI was reduced in DR, especially in temporal and central sectors (P < 0.05). Compared with nonproliferative, proliferative DR exhibited decreased ChT (temporal, P < 0.05; other sectors, P > 0.05), CVI (P > 0.05), and MChVD (P > 0.05). DME eyes demonstrated lower but not statistically significant MChVD (196.449 ± 27.221 µm vs. 205.922 ± 29.134 µm; P > 0.05) and significantly reduced average CVI (0.365 ± 0.032 vs. 0.389 ± 0.040; P = 0.008) compared with non-DME eyes. CONCLUSIONS: DR and DME eyes showed reduced MChVD and CVI, likely owing to microvascular changes leading to ischemia. These findings highlight the need for new choroidal biomarkers to better understand DR's pathogenic mechanisms.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Sadeghi E, Du K, Ajayi O, et al. Three-Dimensional Choroidal Vessels Assessment in Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2025. PMID: 40131298. doi:10.1167/iovs.66.3.50

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。